A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT04224688 · TERMINATED
Trial details
- NCT number
- NCT04224688
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2022-04-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.